These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 17114663)

  • 1. Plasma osteopontin is an independent prognostic marker for head and neck cancers.
    Petrik D; Lavori PW; Cao H; Zhu Y; Wong P; Christofferson E; Kaplan MJ; Pinto HA; Sutphin P; Koong AC; Giaccia AJ; Le QT
    J Clin Oncol; 2006 Nov; 24(33):5291-7. PubMed ID: 17114663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma osteopontin levels in patients with head and neck cancer undergoing chemoradiotherapy.
    Snitcovsky I; Leitão GM; Pasini FS; Brunialti KC; Mangone FR; Maistro S; de Castro G; Villar RC; Federico MH
    Arch Otolaryngol Head Neck Surg; 2009 Aug; 135(8):807-11. PubMed ID: 19687403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of osteopontin in hepatitis B virus-related hepatocellular carcinoma.
    Xie H; Song J; Du R; Liu K; Wang J; Tang H; Bai F; Liang J; Lin T; Liu J; Fan D
    Dig Liver Dis; 2007 Feb; 39(2):167-72. PubMed ID: 17161983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of osteopontin in esophageal squamous cell carcinoma: comparison with common tumor markers.
    Shimada Y; Watanabe G; Kawamura J; Soma T; Okabe M; Ito T; Inoue H; Kondo M; Mori Y; Tanaka E; Imamura M
    Oncology; 2005; 68(2-3):285-92. PubMed ID: 16015046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of osteopontin as a prognostic plasma marker for head and neck squamous cell carcinomas.
    Le QT; Sutphin PD; Raychaudhuri S; Yu SC; Terris DJ; Lin HS; Lum B; Pinto HA; Koong AC; Giaccia AJ
    Clin Cancer Res; 2003 Jan; 9(1):59-67. PubMed ID: 12538452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of elevated osteopontin levels in head and neck cancer patients.
    Eto M; Kodama S; Nomi N; Uemura N; Suzuki M
    Auris Nasus Larynx; 2007 Sep; 34(3):343-6. PubMed ID: 17254728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble Tie-2 receptor levels independently predict locoregional recurrence in head and neck squamous cell carcinoma.
    Homer JJ; Greenman J; Drevs J; Marme D; Stafford ND
    Head Neck; 2002 Aug; 24(8):773-8. PubMed ID: 12203803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Osteopontin as a potential biomarker of metastasis and recurrence for hepatocellular carcinoma].
    Cui BK; Zhang CQ; Zhang Y; Yuan YF; Zhang YQ; Shi M; Chen MS; Li SP; Li JQ
    Ai Zheng; 2006 Jul; 25(7):876-9. PubMed ID: 16831281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of osteopontin expression in T1 and T2 tongue cancers.
    Chien CY; Su CY; Chuang HC; Fang FM; Huang HY; Chen CM; Chen CH; Huang CC
    Head Neck; 2008 Jun; 30(6):776-81. PubMed ID: 18228527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated plasma osteopontin levels in patients with hepatocellular carcinoma.
    Kim J; Ki SS; Lee SD; Han CJ; Kim YC; Park SH; Cho SY; Hong YJ; Park HY; Lee M; Jung HH; Lee KH; Jeong SH
    Am J Gastroenterol; 2006 Sep; 101(9):2051-9. PubMed ID: 16848813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The prognostic significance of preoperative plasma level of osteopontin in combination with intercellular adhesion molecule-1 for patients with hepatocellular carcinoma].
    Zhang H; Ren N; Ye QH; Sun HC; Wang L; Liu YK; Tang ZY; Qin LX
    Zhonghua Wai Ke Za Zhi; 2005 Aug; 43(15):985-8. PubMed ID: 16194354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated plasma osteopontin in metastatic breast cancer associated with increased tumor burden and decreased survival.
    Singhal H; Bautista DS; Tonkin KS; O'Malley FP; Tuck AB; Chambers AF; Harris JF
    Clin Cancer Res; 1997 Apr; 3(4):605-11. PubMed ID: 9815727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of tissue inhibitors of metalloproteinases (TIMP) on course and prognosis of head and neck squamous cell carcinoma].
    Klisho EV; Kondakova IV; Choĭnzonov EL; Shishkin DA; Cheremisina OV; Chuzhevskaia SIu
    Vopr Onkol; 2009; 55(6):717-21. PubMed ID: 20210014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteopontin as a serologic marker for metastatic uveal melanoma: results of a pilot study.
    Reiniger IW; Wolf A; Welge-Lüssen U; Mueller AJ; Kampik A; Schaller UC
    Am J Ophthalmol; 2007 Apr; 143(4):705-7. PubMed ID: 17386288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perioperative changes in osteopontin and TGFβ1 plasma levels and their prognostic impact for radiotherapy in head and neck cancer.
    Polat B; Kaiser P; Wohlleben G; Gehrke T; Scherzad A; Scheich M; Malzahn U; Fischer T; Vordermark D; Flentje M
    BMC Cancer; 2017 Jan; 17(1):6. PubMed ID: 28049456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serial plasma osteopontin levels have prognostic value in metastatic breast cancer.
    Bramwell VH; Doig GS; Tuck AB; Wilson SM; Tonkin KS; Tomiak A; Perera F; Vandenberg TA; Chambers AF
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3337-43. PubMed ID: 16740755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of primary tumor volume after concurrent chemoradiation with daily low-dose cisplatin for advanced-stage head and neck carcinoma.
    Hoebers FJ; Pameijer FA; de Bois J; Heemsbergen W; Balm AJ; Schornagel JH; Rasch CR
    Head Neck; 2008 Sep; 30(9):1216-23. PubMed ID: 18642295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of soluble CD44v6 as a potential serum marker for head and neck squamous cell carcinoma.
    Van Hal NL; Van Dongen GA; Ten Brink CB; Heider KH; Rech-Weichselbraun I; Snow GB; Brakenhoff RH
    Clin Cancer Res; 1999 Nov; 5(11):3534-41. PubMed ID: 10589769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of soluble adhesion molecules CD44 (CD44st, CD44v5, CD44v6), ICAM-1, and VCAM-1 as tumor markers in head and neck cancer.
    Kawano T; Yanoma S; Nakamura Y; Shiono O; Kokatu T; Kubota A; Furukawa M; Tsukuda M
    Am J Otolaryngol; 2005; 26(5):308-13. PubMed ID: 16137528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of mitotic and apoptotic index and the DNA cytometry in head and neck cancer.
    Smilek P; Dusek L; Veselý K; Rottenberg J; Kostrica R
    Neoplasma; 2005; 52(3):199-207. PubMed ID: 15875080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.